Skip to Content

L519 (Carbidopa and Levodopa Extended-Release 25 mg / 100 mg)

Pill with imprint L519 is Purple, Elliptical / Oval and has been identified as Carbidopa and Levodopa Extended-Release 25 mg / 100 mg. It is supplied by Alembic Pharmaceuticals Inc..

Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L519

Carbidopa and Levodopa Extended-Release

Imprint
L519
Strength
25 mg / 100 mg
Color
Purple
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alembic Pharmaceuticals Inc.
National Drug Code (NDC)
62332-0332

Get help with Imprint Code FAQs.

Related Images for "L519"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.